Bio-Techne Corporation
TECHNASDAQHealthcare● Active
$51.99
$-1.19(-2.24%)
Market Cap$8.1B
P/E Ratio—
52W High$72.16
52W Low$43.2
Bio-Techne Corporation (TECH) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · TECH · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.22B | $1.16B | $1.14B | $1.11B | $0.93B |
| Cost of Revenue | $0.43B | $0.39B | $0.37B | $0.35B | $0.30B |
| Gross Profit | $0.79B | $0.77B | $0.77B | $0.76B | $0.63B |
| Gross Margin %(computed) | 64.80% | 66.41% | 67.72% | 68.42% | 67.97% |
| Operating Expenses | |||||
| R&D Expenses | $0.10B | $0.10B | $0.09B | $0.09B | $0.07B |
| G&A Expenses | $0.42B | $0.39B | $0.35B | $0.34B | $0.29B |
| Total Operating Expenses | $0.69B | $0.56B | $0.47B | $0.46B | $0.40B |
| Operating Income | $0.10B | $0.21B | $0.30B | $0.30B | $0.24B |
| Operating Margin %(computed) | 8.38% | 17.83% | 26.30% | 26.83% | 25.49% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.02B | $0.01B | $0.01B | $0.01B |
| Income Before Tax | $0.10B | $0.19B | $0.34B | $0.30B | $0.15B |
| Income Tax Expense | $0.03B | $0.02B | $0.05B | $0.04B | $0.01B |
| Net Income | $0.07B | $0.17B | $0.29B | $0.27B | $0.14B |
| Net Margin %(computed) | 6.02% | 14.50% | 25.10% | 24.61% | 15.08% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.47 | $1.07 | $1.81 | $1.73 | $0.91 |
| Wtd Avg Shares | 0.16B | 0.16B | 0.16B | 0.16B | 0.15B |
| EBITDA | $0.22B | $0.31B | $0.46B | $0.41B | $0.25B |
| EBITDA Margin %(computed) | 17.78% | 27.02% | 40.21% | 37.42% | 26.84% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Bio-Techne Corporation data
About Bio-Techne Corporation (TECH) Income Statement
Bio-Techne Corporation (TECH) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, TECH reported revenue of $1.22B, gross profit of $0.79B (gross margin 64.80%), and net income of $0.07B — a net profit margin of 6.02%.
Frequently asked questions
TECH · 4 questionsBio-Techne Corporation (TECH) reported revenue of $1.22B for 2025, up 5.2% year-over-year.
TECH revenueTECH salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08